(USAC) USA Compression Partners - Overview
Stock: Compression Services, Fleet, Hp, Treating
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.73% |
| Yield on Cost 5y | 23.54% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 96.8% |
| Payout Ratio | 2.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.8% |
| Relative Tail Risk | -7.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -12.57 |
| Character TTM | |
|---|---|
| Beta | 0.874 |
| Beta Downside | 1.200 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.35% |
| CAGR/Max DD | 0.75 |
Description: USAC USA Compression Partners January 11, 2026
USA Compression Partners, LP (NYSE: USAC) is a Dallas-based provider of natural-gas compression and treatment services to oil-field operators, midstream firms, and independent producers across the United States. Its core offerings include compression for gathering, processing, and gas-lift applications, plus gas-treating services such as CO₂ and H₂S removal, dehydration, and cooling.
As of 31 December 2024 the company operates roughly 3.86 million horsepower of compression equipment-a fleet that translates to about 1,200 compressor units and an estimated utilization rate of 85-90 % in a market where U.S. dry-gas production has risen ~3 % YoY since 2022. FY 2024 adjusted EBITDA was approximately $200 million, reflecting an EBITDA margin near 30 % that is typical for the mid-stream equipment niche when compression rates are above 80 % capacity.
Key economic drivers for USAC include sustained growth in U.S. natural-gas output, expanding LNG export capacity (which adds downstream compression demand), and tighter environmental regulations that increase the need for gas-treating services. If you want a data-rich, quantitative deep-dive on USAC’s valuation and risk profile, the ValueRay USAC dashboard is a useful next stop.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 114.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 7.38 > 1.0 |
| NWC/Revenue: 6.74% < 20% (prev 8.52%; Δ -1.79% < -1%) |
| CFO/TA 0.13 > 3% & CFO 336.6m > Net Income 114.9m |
| Net Debt (2.53b) to EBITDA (454.5m): 5.56 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.7m) vs 12m ago 3.75% < -2% |
| Gross Margin: 61.64% > 18% (prev 0.67%; Δ 6096 % > 0.5%) |
| Asset Turnover: 36.30% > 50% (prev 33.16%; Δ 3.15% > 0%) |
| Interest Coverage Ratio: 1.29 > 6 (EBITDA TTM 454.5m / Interest Expense TTM 190.1m) |
Beneish M -3.04
| DSRI: 0.95 (Receivables 100.9m/99.1m, Revenue 991.6m/929.6m) |
| GMI: 1.09 (GM 61.64% / 67.24%) |
| AQI: 0.96 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 1.07 (Revenue 991.6m / 929.6m) |
| TATA: -0.08 (NI 114.9m - CFO 336.6m) / TA 2.66b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of USAC shares?
Over the past week, the price has changed by +1.89%, over one month by +13.07%, over three months by +11.53% and over the past year by +1.26%.
Is USAC a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the USAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.6 | 0.9% |
| Analysts Target Price | 26.6 | 0.9% |
| ValueRay Target Price | 32 | 21.3% |
USAC Fundamental Data Overview February 03, 2026
P/E Forward = 18.4162
P/S = 3.1998
P/B = 24.8274
P/EG = -68.32
Revenue TTM = 991.6m USD
EBIT TTM = 244.3m USD
EBITDA TTM = 454.5m USD
Long Term Debt = 2.53b USD (from longTermDebt, last quarter)
Short Term Debt = 4.39m USD (from shortTermDebt, last fiscal year)
Debt = 2.52b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 2.53b USD (from netDebt column, last quarter)
Enterprise Value = 5.69b USD (3.17b + Debt 2.52b - CCE 14.0k)
Interest Coverage Ratio = 1.29 (Ebit TTM 244.3m / Interest Expense TTM 190.1m)
EV/FCF = 23.60x (Enterprise Value 5.69b / FCF TTM 241.2m)
FCF Yield = 4.24% (FCF TTM 241.2m / Enterprise Value 5.69b)
FCF Margin = 24.33% (FCF TTM 241.2m / Revenue TTM 991.6m)
Net Margin = 11.59% (Net Income TTM 114.9m / Revenue TTM 991.6m)
Gross Margin = 61.64% ((Revenue TTM 991.6m - Cost of Revenue TTM 380.4m) / Revenue TTM)
Gross Margin QoQ = 40.79% (prev 69.25%)
Tobins Q-Ratio = 2.14 (Enterprise Value 5.69b / Total Assets 2.66b)
Interest Expense / Debt = 1.87% (Interest Expense 47.1m / Debt 2.52b)
Taxrate = 6.52% (2.41m / 36.9m)
NOPAT = 228.4m (EBIT 244.3m * (1 - 6.52%))
Current Ratio = 1.36 (Total Current Assets 251.6m / Total Current Liabilities 184.8m)
Debt / Equity = 90.78 (Debt 2.52b / totalStockholderEquity, last fiscal year 27.8m)
Debt / EBITDA = 5.56 (Net Debt 2.53b / EBITDA 454.5m)
Debt / FCF = 10.49 (Net Debt 2.53b / FCF TTM 241.2m)
Total Stockholder Equity = -15.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.21% (Net Income 114.9m / Total Assets 2.66b)
RoE = -754.2% (negative equity) (Net Income TTM 114.9m / Total Stockholder Equity -15.2m)
RoCE = 9.72% (EBIT 244.3m / Capital Employed (Equity -15.2m + L.T.Debt 2.53b))
RoIC = 9.17% (NOPAT 228.4m / Invested Capital 2.49b)
WACC = 5.87% (E(3.17b)/V(5.69b) * Re(9.14%) + D(2.52b)/V(5.69b) * Rd(1.87%) * (1-Tc(0.07)))
Discount Rate = 9.14% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.18%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈163.7m ; Y1≈107.5m ; Y5≈49.0m
Fair Price DCF = N/A (negative equity: EV 1.56b - Net Debt 2.53b = -967.0m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 75.81 | EPS CAGR: 84.78% | SUE: -4.0 | # QB: 0
Revenue Correlation: 97.15 | Revenue CAGR: 12.68% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.49 | Chg30d=+0.018 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.44 | Chg30d=+0.082 | Revisions Net=+1 | Growth EPS=+43.7% | Growth Revenue=+28.3%